|
FR7461M
(enExample)
|
1968-06-19 |
1970-01-05 |
|
|
|
GB1355961A
(en)
|
1970-02-27 |
1974-06-12 |
Wellcome Found |
Preparation of immunosuppressive antilymphocytic serum
|
|
CH594444A5
(enExample)
|
1972-12-04 |
1978-01-13 |
Gerd Birrenbach |
|
|
DK143689C
(da)
|
1975-03-20 |
1982-03-15 |
J Kreuter |
Fremgangsmaade til fremstilling af en adsorberet vaccine
|
|
US4756907A
(en)
|
1978-10-17 |
1988-07-12 |
Stolle Research & Development Corp. |
Active/passive immunization of the internal female reproductive organs
|
|
US4946929A
(en)
|
1983-03-22 |
1990-08-07 |
Massachusetts Institute Of Technology |
Bioerodible articles useful as implants and prostheses having predictable degradation rates
|
|
US6309669B1
(en)
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
|
US4638045A
(en)
|
1985-02-19 |
1987-01-20 |
Massachusetts Institute Of Technology |
Non-peptide polyamino acid bioerodible polymers
|
|
US4631211A
(en)
|
1985-03-25 |
1986-12-23 |
Scripps Clinic & Research Foundation |
Means for sequential solid phase organic synthesis and methods using the same
|
|
US4806621A
(en)
|
1986-01-21 |
1989-02-21 |
Massachusetts Institute Of Technology |
Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
|
|
JPS63122620A
(ja)
|
1986-11-12 |
1988-05-26 |
Sanraku Inc |
ポリ乳酸マイクロスフエア及びその製造方法
|
|
US5736372A
(en)
|
1986-11-20 |
1998-04-07 |
Massachusetts Institute Of Technology |
Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
|
|
US5759830A
(en)
|
1986-11-20 |
1998-06-02 |
Massachusetts Institute Of Technology |
Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
|
|
CA1340581C
(en)
|
1986-11-20 |
1999-06-08 |
Joseph P. Vacanti |
Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
|
|
FR2608988B1
(fr)
|
1986-12-31 |
1991-01-11 |
Centre Nat Rech Scient |
Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
|
|
US5912017A
(en)
|
1987-05-01 |
1999-06-15 |
Massachusetts Institute Of Technology |
Multiwall polymeric microspheres
|
|
US5229490A
(en)
|
1987-05-06 |
1993-07-20 |
The Rockefeller University |
Multiple antigen peptide system
|
|
US5019379A
(en)
|
1987-07-31 |
1991-05-28 |
Massachusetts Institute Of Technology |
Unsaturated polyanhydrides
|
|
US6130082A
(en)
|
1988-05-05 |
2000-10-10 |
American Cyanamid Company |
Recombinant flagellin vaccines
|
|
US4929624A
(en)
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
|
US5010167A
(en)
|
1989-03-31 |
1991-04-23 |
Massachusetts Institute Of Technology |
Poly(amide-and imide-co-anhydride) for biological application
|
|
US5114703A
(en)
|
1989-05-30 |
1992-05-19 |
Alliance Pharmaceutical Corp. |
Percutaneous lymphography using particulate fluorocarbon emulsions
|
|
US5733572A
(en)
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
|
GB9016885D0
(en)
*
|
1990-08-01 |
1990-09-12 |
Scras |
Sustained release pharmaceutical compositions
|
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
ATE156705T1
(de)
|
1991-04-02 |
1997-08-15 |
Biotech Australia Pty Ltd |
Systeme zur oralen freisetzung von mikropartikeln
|
|
US5811447A
(en)
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US6235313B1
(en)
|
1992-04-24 |
2001-05-22 |
Brown University Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
|
EP0654973A4
(en)
|
1992-07-21 |
1995-08-09 |
Gen Hospital Corp |
ARRANGEMENT FOR DELIVERING MEDICINES TO THE LYMPHIC TISSUE.
|
|
GB9216082D0
(en)
|
1992-07-28 |
1992-09-09 |
Univ Nottingham |
Lymphatic delivery composition
|
|
US6608201B2
(en)
|
1992-08-28 |
2003-08-19 |
3M Innovative Properties Company |
Process for preparing 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
FR2695563B1
(fr)
*
|
1992-09-11 |
1994-12-02 |
Pasteur Institut |
Microparticules portant des antigènes et leur utilisation pour l'induction de réponses humorales ou cellulaires.
|
|
WO1994007469A1
(en)
|
1992-09-25 |
1994-04-14 |
Dynagen, Inc. |
An immunobooster for delayed release of immunogen
|
|
US5399665A
(en)
|
1992-11-05 |
1995-03-21 |
Massachusetts Institute Of Technology |
Biodegradable polymers for cell transplantation
|
|
DE69418699T2
(de)
|
1993-01-11 |
1999-09-30 |
Dana-Farber Cancer Institute, Boston |
Induktion der antworten zytotoxischer t-lymphozyten
|
|
US5512600A
(en)
|
1993-01-15 |
1996-04-30 |
Massachusetts Institute Of Technology |
Preparation of bonded fiber structures for cell implantation
|
|
US5514378A
(en)
|
1993-02-01 |
1996-05-07 |
Massachusetts Institute Of Technology |
Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
|
|
JPH08507070A
(ja)
*
|
1993-02-22 |
1996-07-30 |
アルザ・コーポレーション |
活性物質の経口投与のための組成物
|
|
DE59403734D1
(de)
|
1993-03-17 |
1997-09-18 |
Silica Gel Gmbh |
Superparamagnetische teilchen, verfahren zu ihrer herstellung und verwendung derselben
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
WO1995003035A1
(en)
|
1993-07-23 |
1995-02-02 |
Massachusetts Institute Of Technology |
Polymerized liposomes with enhanced stability for oral delivery
|
|
US5798340A
(en)
|
1993-09-17 |
1998-08-25 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
US5500161A
(en)
*
|
1993-09-21 |
1996-03-19 |
Massachusetts Institute Of Technology And Virus Research Institute |
Method for making hydrophobic polymeric microparticles
|
|
DE69529054T2
(de)
|
1994-02-28 |
2003-08-21 |
Nanopharm Ag |
System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung
|
|
GB9412273D0
(en)
*
|
1994-06-18 |
1994-08-10 |
Univ Nottingham |
Administration means
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
ES2366201T3
(es)
|
1994-07-15 |
2011-10-18 |
University Of Iowa Research Foundation |
Oligonucleótidos inmunmoduladores.
|
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
US5716404A
(en)
|
1994-12-16 |
1998-02-10 |
Massachusetts Institute Of Technology |
Breast tissue engineering
|
|
EP0805678B1
(en)
|
1995-01-05 |
2003-10-29 |
THE BOARD OF REGENTS acting for and on behalf of THE UNIVERSITY OF MICHIGAN |
Surface-modified nanoparticles and method of making and using same
|
|
US6123727A
(en)
|
1995-05-01 |
2000-09-26 |
Massachusetts Institute Of Technology |
Tissue engineered tendons and ligaments
|
|
WO1997004747A1
(en)
|
1995-07-27 |
1997-02-13 |
Dunn James M |
Drug delivery systems for macromolecular drugs
|
|
AU710347B2
(en)
|
1995-08-31 |
1999-09-16 |
Alkermes Controlled Therapeutics, Inc. |
Composition for sustained release of an agent
|
|
US6095148A
(en)
|
1995-11-03 |
2000-08-01 |
Children's Medical Center Corporation |
Neuronal stimulation using electrically conducting polymers
|
|
US5902599A
(en)
|
1996-02-20 |
1999-05-11 |
Massachusetts Institute Of Technology |
Biodegradable polymer networks for use in orthopedic and dental applications
|
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US5922695A
(en)
|
1996-07-26 |
1999-07-13 |
Gilead Sciences, Inc. |
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
|
|
US6368598B1
(en)
|
1996-09-16 |
2002-04-09 |
Jcrt Radiation Oncology Support Services, Inc. |
Drug complex for treatment of metastatic prostate cancer
|
|
IL129319A0
(en)
|
1996-10-25 |
2000-02-17 |
Minnesota Mining & Mfg |
Immune response modifier compounds for treatment of TH2 mediated and related diseases
|
|
US6042820A
(en)
|
1996-12-20 |
2000-03-28 |
Connaught Laboratories Limited |
Biodegradable copolymer containing α-hydroxy acid and α-amino acid units
|
|
US6214806B1
(en)
|
1997-02-28 |
2001-04-10 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CPC dinucleotide in the treatment of LPS-associated disorders
|
|
AU753688B2
(en)
|
1997-03-10 |
2002-10-24 |
Ottawa Civic Loeb Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US6211159B1
(en)
|
1997-04-11 |
2001-04-03 |
University Of Toronto |
Flagellin gene, FlaC of campylobacter
|
|
US6060082A
(en)
*
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
|
CA2301575C
(en)
|
1997-05-20 |
2003-12-23 |
Ottawa Civic Hospital Loeb Research Institute |
Vectors and methods for immunization or therapeutic protocols
|
|
US5837752A
(en)
|
1997-07-17 |
1998-11-17 |
Massachusetts Institute Of Technology |
Semi-interpenetrating polymer networks
|
|
US6989435B2
(en)
|
1997-09-11 |
2006-01-24 |
Cambridge University Technical Services Ltd. |
Compounds and methods to inhibit or augment an inflammatory response
|
|
DE19745950A1
(de)
|
1997-10-17 |
1999-04-22 |
Dds Drug Delivery Service Ges |
Arzneistoffträgerpartikel für die gewebespezifische Arzneistoffapplikation
|
|
ATE247654T1
(de)
|
1997-11-28 |
2003-09-15 |
Sumitomo Pharma |
Neue heterozyklische verbindungen
|
|
US6197229B1
(en)
*
|
1997-12-12 |
2001-03-06 |
Massachusetts Institute Of Technology |
Method for high supercoiled DNA content microspheres
|
|
US6254890B1
(en)
|
1997-12-12 |
2001-07-03 |
Massachusetts Institute Of Technology |
Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acids
|
|
FR2775435B1
(fr)
*
|
1998-02-27 |
2000-05-26 |
Bioalliance Pharma |
Nanoparticules comprenant au moins un polymere et au moins un compose apte a complexer un ou plusieurs principes actifs
|
|
US6232287B1
(en)
|
1998-03-13 |
2001-05-15 |
The Burnham Institute |
Molecules that home to various selected organs or tissues
|
|
US6506577B1
(en)
|
1998-03-19 |
2003-01-14 |
The Regents Of The University Of California |
Synthesis and crosslinking of catechol containing copolypeptides
|
|
US6632922B1
(en)
|
1998-03-19 |
2003-10-14 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6686446B2
(en)
|
1998-03-19 |
2004-02-03 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
JP2002510644A
(ja)
|
1998-04-03 |
2002-04-09 |
ユニバーシティ オブ アイオワ リサーチ ファウンデーション |
免疫治療用オリゴヌクレオチドおよびサイトカインを用いる免疫系刺激のための方法および産物
|
|
WO1999056755A1
(en)
|
1998-05-06 |
1999-11-11 |
University Of Iowa Research Foundation |
Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides
|
|
DE19827164A1
(de)
|
1998-06-18 |
1999-12-23 |
Merck Patent Gmbh |
Katalytisch Titan(IV)-oxid vermittelte geminale symmetrische Dialkylierung von Carbonsäureamiden
|
|
US6242589B1
(en)
|
1998-07-14 |
2001-06-05 |
Isis Pharmaceuticals, Inc. |
Phosphorothioate oligonucleotides having modified internucleoside linkages
|
|
DE69930642T2
(de)
|
1998-07-29 |
2006-12-28 |
Chiron Corp., Emeryville |
Mikropartikel mit adsorbenten oberflächen, verfahren zu ihrer herstellung und ihrer verwendung
|
|
DE19839214C1
(de)
|
1998-08-28 |
2000-05-25 |
Aventis Res & Tech Gmbh & Co |
Verfahren zur Herstellung von sphärischen Mikropartikeln mit glatter Oberfläche, die ganz oder teilweise aus mindestens einem wasserunlöslichen linearen Polysaccharid bestehen, sowie mit diesem Verfahren erhältliche Mikropartikel und deren Verwendung
|
|
US6306640B1
(en)
|
1998-10-05 |
2001-10-23 |
Genzyme Corporation |
Melanoma antigenic peptides
|
|
DK1126826T6
(en)
|
1998-11-02 |
2019-06-24 |
Alkermes Pharma Ireland Ltd |
Multiparticulate modified release of methylphenidate
|
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US7238711B1
(en)
|
1999-03-17 |
2007-07-03 |
Cambridge University Technical Services Ltd. |
Compounds and methods to inhibit or augment an inflammatory response
|
|
US6444192B1
(en)
|
1999-02-05 |
2002-09-03 |
The Regents Of The University Of California |
Diagnostic imaging of lymph structures
|
|
US7238368B2
(en)
|
1999-04-23 |
2007-07-03 |
Alza Corporation |
Releasable linkage and compositions containing same
|
|
HUP0201425A3
(en)
|
1999-04-23 |
2006-07-28 |
Hadasit Med Res Service |
Conjugate having a cleavable linkage for use in a liposome
|
|
US6800296B1
(en)
|
1999-05-19 |
2004-10-05 |
Massachusetts Institute Of Technology |
Modification of surfaces using biological recognition events
|
|
US6815170B1
(en)
|
1999-06-30 |
2004-11-09 |
John Wayne Cancer Institute |
Methods for lymph node identification
|
|
EP1202671A4
(en)
*
|
1999-08-13 |
2004-11-10 |
Point Biomedical Corp |
MICROPARTICLES USEFUL AS ULTRASONIC CONTRAST AGENTS FOR THE LYMPHATIC SYSTEM
|
|
CA2391534A1
(en)
|
1999-11-15 |
2001-05-25 |
Drug Innovation & Design, Inc. |
Selective cellular targeting: multifunctional delivery vehicles
|
|
WO2001051665A2
(en)
|
2000-01-13 |
2001-07-19 |
Nanosphere Inc. |
Nanoparticles having oligonucleotides attached thereto and uses therefor
|
|
US20050020525A1
(en)
|
2002-02-20 |
2005-01-27 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
|
|
US20050032733A1
(en)
|
2001-05-18 |
2005-02-10 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA)
|
|
US8202979B2
(en)
|
2002-02-20 |
2012-06-19 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
|
|
JP4751556B2
(ja)
|
2000-02-28 |
2011-08-17 |
ジーンシーグス， インコーポレイテッド |
ナノカプセルカプセル化システムおよび方法
|
|
US7129222B2
(en)
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
|
US7192725B2
(en)
|
2000-05-19 |
2007-03-20 |
University Of Toronto |
Flagellin gene, flaC of Campylobacter
|
|
WO2002100325A2
(en)
|
2000-10-13 |
2002-12-19 |
Ligocyte Pharmaceuticals, Inc. |
Polyvalent nanoparticles
|
|
GB0025414D0
(en)
|
2000-10-16 |
2000-11-29 |
Consejo Superior Investigacion |
Nanoparticles
|
|
JP4070605B2
(ja)
|
2000-10-19 |
2008-04-02 |
アイトゲノッシスシェ・テヒニッシュ・ホーホシューレ・ツューリヒ |
多官能性自己集成系のためのブロックコポリマー
|
|
US7592008B2
(en)
|
2000-11-20 |
2009-09-22 |
The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois |
Membrane scaffold proteins
|
|
US7097837B2
(en)
|
2001-02-19 |
2006-08-29 |
Pharmexa A/S |
Synthetic vaccine agents
|
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
|
EP1528937B1
(en)
|
2001-06-05 |
2016-08-10 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
JP2005514326A
(ja)
|
2001-07-10 |
2005-05-19 |
コリクサ コーポレイション |
ミクロスフェア中に封入されたタンパク質およびアジュバントを送達するための組成物および方法
|
|
JP4607452B2
(ja)
|
2001-08-07 |
2011-01-05 |
ダイナバックス テクノロジーズ コーポレイション |
免疫調節性組成物、製剤およびその使用方法
|
|
WO2003020797A1
(en)
|
2001-08-30 |
2003-03-13 |
The Regents Of The University Of California |
Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
|
|
US8088388B2
(en)
|
2002-02-14 |
2012-01-03 |
United Biomedical, Inc. |
Stabilized synthetic immunogen delivery system
|
|
CA2476626A1
(en)
|
2002-02-20 |
2003-08-28 |
Chiron Corporation |
Microparticles with adsorbed polypeptide-containing molecules
|
|
US20030232013A1
(en)
|
2002-02-22 |
2003-12-18 |
Gary Sieckman |
Therapeutic and diagnostic targeting of cancers cells with tumor homing peptides
|
|
US7635463B2
(en)
*
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
|
EP3006043B1
(en)
|
2002-04-04 |
2019-05-29 |
Zoetis Belgium S.A. |
Immunostimulatory g,u-containing oligoribonucleotides
|
|
US20040038303A1
(en)
*
|
2002-04-08 |
2004-02-26 |
Unger Gretchen M. |
Biologic modulations with nanoparticles
|
|
US7285289B2
(en)
|
2002-04-12 |
2007-10-23 |
Nagy Jon O |
Nanoparticle vaccines
|
|
US20080233181A1
(en)
|
2002-04-12 |
2008-09-25 |
Nagy Jon O |
Nanoparticle adjuvants for sub-unit vaccines
|
|
EP1499895B1
(en)
*
|
2002-04-22 |
2008-05-07 |
University Of Florida |
Functionalized nanoparticles and methods of use
|
|
JP4638225B2
(ja)
*
|
2002-05-30 |
2011-02-23 |
ザ スクリプス リサーチ インスティテュート |
銅を触媒とするアジドとアセチレンのライゲーション
|
|
WO2003105780A2
(en)
|
2002-06-18 |
2003-12-24 |
Epigenesis Pharmaceuticals, Inc. |
A dry powder oligonucleotide formulation, preparation and its uses
|
|
AU2003269904A1
(en)
|
2002-07-10 |
2004-01-23 |
The Ohio State University Research Foundation |
Antigen-polymer compositions
|
|
US6932971B2
(en)
|
2002-07-18 |
2005-08-23 |
Cytos Biotechnology Ag |
Hapten-carrier conjugates and uses thereof
|
|
US7488792B2
(en)
|
2002-08-28 |
2009-02-10 |
Burnham Institute For Medical Research |
Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
|
|
US20060189554A1
(en)
|
2002-09-24 |
2006-08-24 |
Russell Mumper |
Nanoparticle-Based vaccine delivery system containing adjuvant
|
|
US7008411B1
(en)
*
|
2002-09-30 |
2006-03-07 |
Advanced Cardiovascular Systems, Inc. |
Method and apparatus for treating vulnerable plaque
|
|
NO20024755D0
(no)
|
2002-10-03 |
2002-10-03 |
Amersham Health As |
Metode
|
|
SE0203687D0
(sv)
*
|
2002-12-13 |
2002-12-13 |
Ian Harwigsson Med Adagit Fa |
Pharmaceutical Porous Particles
|
|
US20040156846A1
(en)
|
2003-02-06 |
2004-08-12 |
Triton Biosystems, Inc. |
Therapy via targeted delivery of nanoscale particles using L6 antibodies
|
|
JP4509999B2
(ja)
|
2003-02-17 |
2010-07-21 |
ブルクハルト，ペーター |
医薬送達及び抗原提示システムとしてのペプチドナノ粒子
|
|
US20040191215A1
(en)
|
2003-03-25 |
2004-09-30 |
Michael Froix |
Compositions for induction of a therapeutic response
|
|
WO2004084940A1
(en)
|
2003-03-26 |
2004-10-07 |
Cytos Biotechnology Ag |
Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
|
|
WO2004084871A1
(en)
|
2003-03-26 |
2004-10-07 |
Ltt Bio-Pharma Co., Ltd. |
Intravenous nanoparticles for targenting drug delivery and sustained drug release
|
|
US7731967B2
(en)
*
|
2003-04-30 |
2010-06-08 |
Novartis Vaccines And Diagnostics, Inc. |
Compositions for inducing immune responses
|
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
|
EP1646427A1
(en)
|
2003-07-22 |
2006-04-19 |
Cytos Biotechnology AG |
Cpg-packaged liposomes
|
|
US20050042298A1
(en)
*
|
2003-08-20 |
2005-02-24 |
Pardridge William M. |
Immunonanoparticles
|
|
US20070014807A1
(en)
|
2003-09-03 |
2007-01-18 |
Maida Anthony E Iii |
Multiplex vaccine
|
|
US7943179B2
(en)
|
2003-09-23 |
2011-05-17 |
Massachusetts Institute Of Technology |
pH triggerable polymeric particles
|
|
US20080160089A1
(en)
*
|
2003-10-14 |
2008-07-03 |
Medivas, Llc |
Vaccine delivery compositions and methods of use
|
|
JP2007514519A
(ja)
|
2003-10-20 |
2007-06-07 |
ウィリアム・マーシュ・ライス・ユニバーシティ |
ポリマー及び帯電ナノ粒子からなるマイクロカプセルを製造する方法
|
|
EP1691780A2
(en)
|
2003-11-21 |
2006-08-23 |
Alza Corporation |
Gene delivery mediated by liposome-dna complex with cleavable peg surface modification
|
|
WO2005055949A2
(en)
*
|
2003-12-09 |
2005-06-23 |
The Children's Hospital Of Philadelphia |
Sustained release preparations composed of biocompatible complex microparticles
|
|
KR101376715B1
(ko)
|
2003-12-19 |
2014-03-27 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
소프트 또는 임프린트 리소그래피를 이용하여 분리된 마이크로- 및 나노- 구조를 제작하는 방법
|
|
US20050191294A1
(en)
|
2003-12-31 |
2005-09-01 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy
|
|
US20070087986A1
(en)
|
2004-01-26 |
2007-04-19 |
Brett Premack |
Compositions and methods for enhancing immunity by chemoattractant adjuvants
|
|
WO2005097993A2
(en)
|
2004-02-19 |
2005-10-20 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory viral rna oligonucleotides
|
|
EP1735010A4
(en)
*
|
2004-04-09 |
2008-08-27 |
3M Innovative Properties Co |
METHODS, COMPOSITIONS AND PREPARATIONS FOR ADMINISTRATION OF IMMUNE RESPONSE MODIFIERS (MRI)
|
|
ES2246695B1
(es)
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
|
|
US20060017339A1
(en)
*
|
2004-06-03 |
2006-01-26 |
Lalit Chordia |
Brushless canned motor
|
|
CA2569590C
(en)
|
2004-06-11 |
2014-04-01 |
Riken |
Drug having regulatory cell ligand contained in liposome
|
|
US7713550B2
(en)
|
2004-06-15 |
2010-05-11 |
Andrx Corporation |
Controlled release sodium valproate formulation
|
|
AU2005326322B2
(en)
|
2004-07-01 |
2009-02-05 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
|
US20080206270A1
(en)
|
2004-07-08 |
2008-08-28 |
Minev Boris R |
Enhancing Class I Antigen Presentation With Synthetic Sequences
|
|
US8017151B2
(en)
|
2004-09-07 |
2011-09-13 |
Board Of Regents Of The University Of Nebraska By And Behalf Of The University Of Nebraska Medical Center |
Amphiphilic polymer-protein conjugates and methods of use thereof
|
|
CN1692943A
(zh)
|
2004-09-17 |
2005-11-09 |
四川大学 |
CpG DNA分子抗感染免疫制剂的制备和应用
|
|
GB0421296D0
(en)
|
2004-09-24 |
2004-10-27 |
Angiogene Pharm Ltd |
Bioreductively-activated prodrugs
|
|
WO2006037979A2
(en)
|
2004-10-01 |
2006-04-13 |
Midatech Limited |
Nanoparticles comprising antigens and adjuvants and immunogenic structure
|
|
CA2583389A1
(en)
|
2004-10-07 |
2006-04-20 |
Emory University |
Multifunctional nanoparticles conjugates and their use
|
|
WO2007001448A2
(en)
|
2004-11-04 |
2007-01-04 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
US9789171B2
(en)
|
2004-11-05 |
2017-10-17 |
The General Hospital Corporation |
Anti-fugetactic agents for the treatment of ovarian cancer
|
|
AU2005334819B2
(en)
|
2004-11-15 |
2011-11-24 |
Novartis Vaccines And Diagnostics Inc. |
Immunogenic compositions containing anthrax antigen, biodegradable polymer microparticles, and polynucleotide-containing immunological adjuvant
|
|
US20060111271A1
(en)
*
|
2004-11-24 |
2006-05-25 |
Cerny Erich H |
Active and passive immunization against pharmacologically active hapten molecules using a synthetic carrier compound composed of similar elements
|
|
CA2590768A1
(en)
|
2004-12-14 |
2006-06-22 |
Alnylam Pharmaceuticals, Inc. |
Rnai modulation of mll-af4 and uses thereof
|
|
US20060257359A1
(en)
|
2005-02-28 |
2006-11-16 |
Cedric Francois |
Modifying macrophage phenotype for treatment of disease
|
|
WO2006102395A2
(en)
|
2005-03-22 |
2006-09-28 |
Medstar Health Inc |
Delivery systems and methods for diagnosing and treating cardiovascular diseases
|
|
US20080305161A1
(en)
|
2005-04-13 |
2008-12-11 |
Pfizer Inc |
Injectable depot formulations and methods for providing sustained release of nanoparticle compositions
|
|
EP1899467A2
(en)
|
2005-04-26 |
2008-03-19 |
Coley Pharmaceutical GmbH |
Modified oligoribonucleotide analogs with enhances immunostimulatory activity
|
|
CN101217967B
(zh)
|
2005-05-04 |
2014-09-10 |
诺松制药股份公司 |
镜像异构体的新用途
|
|
US20100062968A1
(en)
*
|
2005-05-10 |
2010-03-11 |
Bali Pulendran |
Novel strategies for delivery of active agents using micelles and particles
|
|
CA2605551A1
(en)
*
|
2005-05-10 |
2006-11-16 |
Naomi Balaban |
Compositions for administering rnaiii-inhibiting peptides
|
|
CA2614049C
(en)
|
2005-07-06 |
2014-12-02 |
Molly S. Shoichet |
Method of biomolecule immobilization on polymers using click-type chemistry
|
|
CN103315944B
(zh)
|
2005-08-12 |
2016-03-30 |
刘江 |
用于淋巴靶向的方法和装置
|
|
WO2007028341A1
(fr)
*
|
2005-09-09 |
2007-03-15 |
Beijing Diacrid Medical Technology Co., Ltd. |
Nanomicelles servant de medicaments anticancereux a polyethylene phospholipides glycolyles contenant des vinca alcaloides
|
|
CN102517292B
(zh)
|
2005-11-25 |
2014-12-24 |
佐蒂斯比利时股份有限公司 |
免疫刺激性寡核糖核苷酸
|
|
EP1954252B1
(en)
|
2005-12-02 |
2016-02-03 |
GlaxoSmithKline Biologicals SA |
Nanoparticles for use in immunogenic compositions
|
|
US20070184068A1
(en)
|
2005-12-14 |
2007-08-09 |
Cytos Biotechnology Ag |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
|
WO2007070682A2
(en)
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
|
US7842312B2
(en)
|
2005-12-29 |
2010-11-30 |
Cordis Corporation |
Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same
|
|
EP1986685A4
(en)
*
|
2006-01-31 |
2009-02-25 |
Medivas Llc |
COMPOSITIONS FOR DISPENSING A VACCINATE AND METHOD FOR THE APPLICATION THEREOF
|
|
US8021689B2
(en)
*
|
2006-02-21 |
2011-09-20 |
Ecole Polytechnique Federale de Lausanne (“EPFL”) |
Nanoparticles for immunotherapy
|
|
US8431160B2
(en)
|
2006-02-24 |
2013-04-30 |
Novartis Ag |
Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions
|
|
WO2008105773A2
(en)
|
2006-03-31 |
2008-09-04 |
Massachusetts Institute Of Technology |
System for targeted delivery of therapeutic agents
|
|
US20100247653A1
(en)
|
2006-04-11 |
2010-09-30 |
Hans Lautenschlager |
Nanoparticles containing nicotine and/or cotinine, dispersions, and use thereof
|
|
US8367113B2
(en)
*
|
2006-05-15 |
2013-02-05 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
|
WO2007137117A2
(en)
|
2006-05-17 |
2007-11-29 |
Massachusetts Institute Of Technology |
Aptamer-directed drug delivery
|
|
EP2530086B1
(en)
|
2006-06-12 |
2019-03-20 |
Kuros Biosciences AG |
Processes for packaging oligonucleotides into virus-like particles of RNA bacteriophages
|
|
US20080014281A1
(en)
|
2006-06-16 |
2008-01-17 |
Florida Atlantic University |
Chitin Micro-Particles As An Adjuvant
|
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
|
WO2008019142A2
(en)
|
2006-08-04 |
2008-02-14 |
Massachusetts Institute Of Technology |
Oligonucleotide systems for targeted intracellular delivery
|
|
WO2008019366A2
(en)
|
2006-08-07 |
2008-02-14 |
Ludwig Institute For Cancer Research |
Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens
|
|
CL2007002336A1
(es)
|
2006-08-11 |
2008-02-08 |
M S Panacea Biotec Ltd |
Composicion que tiene particulas que comprende elementos inorganicos, uno o mas ingredientes activos y opcionalmente, agentes moduladores de la tasa de liberacion; procedimiento para prepararla; las particulas, util para la entrega de ingredientes ac
|
|
WO2008033432A2
(en)
|
2006-09-12 |
2008-03-20 |
Coley Pharmaceutical Group, Inc. |
Immune modulation by chemically modified ribonucleosides and oligoribonucleotides
|
|
US9017697B2
(en)
|
2006-10-12 |
2015-04-28 |
The University Of Queensland |
Compositions and methods for modulating immune responses
|
|
WO2008147456A2
(en)
|
2006-11-20 |
2008-12-04 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
|
AU2007333225B2
(en)
|
2006-12-08 |
2014-06-12 |
Massachusetts Institute Of Technology |
Delivery of nanoparticles and/or agents to cells
|
|
WO2008071774A1
(en)
|
2006-12-14 |
2008-06-19 |
Cytos Biotechnology Ag |
Purification process for coat protein of rna bacteriophages
|
|
US20080149123A1
(en)
*
|
2006-12-22 |
2008-06-26 |
Mckay William D |
Particulate material dispensing hairbrush with combination bristles
|
|
AU2008227128B2
(en)
*
|
2007-02-07 |
2012-12-06 |
The Regents Of The University Of California |
Conjugates of synthetic TLR agonists and uses therefor
|
|
WO2008098165A2
(en)
|
2007-02-09 |
2008-08-14 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
|
US8889117B2
(en)
|
2007-02-15 |
2014-11-18 |
Yale University |
Modular nanoparticles for adaptable vaccines
|
|
US20100151031A1
(en)
|
2007-03-23 |
2010-06-17 |
Desimone Joseph M |
Discrete size and shape specific organic nanoparticles designed to elicit an immune response
|
|
US11246831B2
(en)
|
2007-03-30 |
2022-02-15 |
Particle Sciences, Inc. |
Particle formulations and uses thereof
|
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
|
JP2010523595A
(ja)
|
2007-04-04 |
2010-07-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
ポリ（アミノ酸）ターゲッティング部分
|
|
US20090226525A1
(en)
|
2007-04-09 |
2009-09-10 |
Chimeros Inc. |
Self-assembling nanoparticle drug delivery system
|
|
WO2008127532A1
(en)
|
2007-04-12 |
2008-10-23 |
Emory University |
Novel strategies for delivery of active agents using micelles and particles
|
|
US8394914B2
(en)
|
2007-08-24 |
2013-03-12 |
Board Of Trustees Of Michigan State University |
Functional polyglycolide nanoparticles derived from unimolecular micelles
|
|
WO2009038685A1
(en)
|
2007-09-18 |
2009-03-26 |
The Scripps Research Institute |
Ligands for copper-catalyzed azide-alkyne cycloaddition reactions
|
|
CA2702083C
(en)
|
2007-10-12 |
2021-11-30 |
Massachusetts Institute Of Technology |
Vaccine nanotechnology
|
|
WO2009052837A2
(en)
*
|
2007-10-24 |
2009-04-30 |
Tallinn University Of Technology |
Maldi ms-based high-throughput screening method for substances inhibiting aggregation of alzheimer's amyloid beta peptides
|
|
AU2008335457B2
(en)
*
|
2007-12-07 |
2015-04-16 |
Glaxosmithkline Biologicals S.A. |
Compositions for inducing immune responses
|
|
AU2009221419B2
(en)
|
2008-02-01 |
2013-09-26 |
Alpha-O Peptides Ag |
Self-assembling peptide nanoparticles useful as vaccines
|
|
WO2009106999A2
(en)
|
2008-02-28 |
2009-09-03 |
Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts |
Hollow nanoparticles and uses thereof
|
|
CN102014874A
(zh)
|
2008-03-04 |
2011-04-13 |
流体科技公司 |
免疫调节剂颗粒和治疗方法
|
|
US20090297621A1
(en)
|
2008-06-03 |
2009-12-03 |
Abbott Cardiovascular Systems Inc. |
Microparticles For The Treatment Of Disease
|
|
US8613951B2
(en)
|
2008-06-16 |
2013-12-24 |
Bind Therapeutics, Inc. |
Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
|
|
KR20160116062A
(ko)
|
2008-06-16 |
2016-10-06 |
바인드 쎄라퓨틱스, 인크. |
약물 부하된 중합체성 나노입자, 및 이의 제조 및 사용 방법
|
|
WO2010003009A2
(en)
*
|
2008-07-01 |
2010-01-07 |
Emory University |
Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors
|
|
EP2328614A1
(en)
|
2008-08-06 |
2011-06-08 |
Novartis AG |
Microparticles for use in immunogenic compositions
|
|
UA103195C2
(uk)
|
2008-08-11 |
2013-09-25 |
Глаксосмитклайн Ллк |
Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
|
|
WO2010018132A1
(en)
|
2008-08-11 |
2010-02-18 |
Smithkline Beecham Corporation |
Compounds
|
|
WO2010018131A1
(en)
|
2008-08-11 |
2010-02-18 |
Smithkline Beecham Corporation |
Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
|
|
JP5519670B2
(ja)
|
2008-08-11 |
2014-06-11 |
グラクソスミスクライン エルエルシー |
アレルギー性、炎症性及び感染性疾患治療用のプリン誘導体
|
|
US8323696B2
(en)
*
|
2008-08-29 |
2012-12-04 |
Ecole Polytechnique Federale De Lausanne |
Nanoparticles for immunotherapy
|
|
WO2010039861A2
(en)
|
2008-09-30 |
2010-04-08 |
The Regents Of The University Of Michigan |
Dendrimer conjugates
|
|
US8343497B2
(en)
*
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
WO2010115046A2
(en)
|
2009-04-01 |
2010-10-07 |
University Of Miami |
Vaccine compositions and methods of use thereof
|
|
EA201101530A1
(ru)
|
2009-04-21 |
2012-03-30 |
Селекта Байосайенсиз, Инк. |
ИММУНОНАНОТЕРАПИЯ, ОБЕСПЕЧИВАЮЩАЯ Th1-СМЕЩЕННЫЙ ОТВЕТ
|
|
JP5738278B2
(ja)
|
2009-05-01 |
2015-06-24 |
キアジェン ゲイサーズバーグ インコーポレイテッド |
試料中のｒｎａスプライシング形態を検出するための非標的増幅法
|
|
EA201500447A1
(ru)
*
|
2009-05-27 |
2017-03-31 |
Селекта Байосайенсиз, Инк. |
НАЦЕЛЕННЫЕ СИНТЕТИЧЕСКИЕ НАНОНОСИТЕЛИ С pH-ЧУВСТВИТЕЛЬНЫМ ВЫСВОБОЖДЕНИЕМ ИММУНОМОДУЛИРУЮЩИХ СРЕДСТВ
|
|
EP2451485B1
(en)
|
2009-07-07 |
2016-03-02 |
The Research Foundation Of State University Of New York |
Lipidic compositions for induction of immune tolerance
|
|
MX343908B
(es)
|
2009-08-26 |
2016-11-28 |
Selecta Biosciences Inc * |
Composiciones que inducen la ayuda de las células t.
|
|
US9295649B2
(en)
|
2009-12-15 |
2016-03-29 |
Bind Therapeutics, Inc. |
Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
|
|
WO2011085231A2
(en)
|
2010-01-08 |
2011-07-14 |
Selecta Biosciences, Inc. |
Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines
|
|
US20110229556A1
(en)
|
2010-03-19 |
2011-09-22 |
Massachusetts Institute Of Technology |
Lipid-coated polymer particles for immune stimulation
|
|
US20110272836A1
(en)
|
2010-04-12 |
2011-11-10 |
Selecta Biosciences, Inc. |
Eccentric vessels
|
|
US20110262491A1
(en)
|
2010-04-12 |
2011-10-27 |
Selecta Biosciences, Inc. |
Emulsions and methods of making nanocarriers
|
|
WO2011150264A2
(en)
|
2010-05-26 |
2011-12-01 |
Selecta Biosciences, Inc. |
Synthetic nanocarrier combination vaccines
|
|
US20120058154A1
(en)
*
|
2010-08-20 |
2012-03-08 |
Selecta Biosciences, Inc. |
Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus m2e
|
|
MX2013002173A
(es)
*
|
2010-08-23 |
2013-05-06 |
Selecta Biosciences Inc |
Formas farmaceuticas dirigidas de epitopos multiples para la induccion de una respuesta inmunologica frente a antigenos.
|
|
EA201390660A1
(ru)
|
2010-11-05 |
2013-11-29 |
Селекта Байосайенсиз, Инк. |
Модифицированные никотиновые соединения и связанные способы
|
|
WO2012092552A1
(en)
|
2010-12-30 |
2012-07-05 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers with reactive groups that release biologically active agents
|
|
EP2694040A4
(en)
|
2011-03-25 |
2014-09-03 |
Selecta Biosciences Inc |
SYNTHETIC NANOTRACKERS WITH OSMOTICALLY MEDIATED RELEASE
|
|
AU2012249540B2
(en)
|
2011-04-29 |
2017-07-13 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
|
|
CA2843274A1
(en)
*
|
2011-07-29 |
2013-02-07 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses
|
|
US20130059009A1
(en)
|
2011-09-06 |
2013-03-07 |
Selecta Biosciences, Inc. |
Compositions and methods for producing antigen-specific induced tolerogenic dendritic cells with synthetic nanocarriers
|
|
EP2991646B1
(en)
|
2013-05-03 |
2020-10-07 |
Selecta Biosciences, Inc. |
Methods and compositions for enhancing cd4+ regulatory t cells
|
|
KR102631173B1
(ko)
|
2013-06-04 |
2024-01-31 |
셀렉타 바이오사이언시즈, 인크. |
비-면역억제성 항원 특이적 면역요법제의 반복 투여
|
|
US20150359865A1
(en)
|
2014-06-17 |
2015-12-17 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers for t-cell-mediated autoimmune disease
|
|
US20160220501A1
(en)
|
2015-02-03 |
2016-08-04 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
|
|
EA201692512A1
(ru)
|
2014-06-25 |
2017-07-31 |
Селекта Байосайенсиз, Инк. |
Способы и композиции для лечения синтетическими наноносителями и ингибиторами иммунной контрольной точки
|
|
EP3189147A1
(en)
|
2014-09-07 |
2017-07-12 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating gene expression modulating anti-viral transfer vector immune responses
|
|
DK3834823T3
(da)
|
2014-11-05 |
2024-04-08 |
Cartesian Therapeutics Inc |
Fremgangsmåder og sammensætninger relateret til anvendelsen af overfladeaktive stoffer med lav hlb ved fremstilling af syntetiske nanobærere, som omfatter en rapalog
|